Meanwhile, CRISPR-based genetic ablation of LMP7 (gene name PSMB8) in the human pancreatic cancer cell line SW 1990 resulted in complete loss of LMP7 staining with EPR14482(B) (Supplementary Figure S1B). The gene discussed is PSMB8; the disease is familial pancreatic carcinoma.